BioCentury | Oct 30, 2018
Company News

Management tracks: Blueprint, Clovis

...Mass.) hired Jeffrey Young as its first CFO. He was CFO, treasurer and secretary at Juniper Pharmaceuticals Inc....
BioCentury | Jun 9, 2017
Company News

Management tracks

...cancer company 2X Oncology Inc. (Cambridge, Mass.) named George Elston CEO. He was CFO at Juniper Pharmaceuticals Inc....
BioCentury | Jan 7, 2017
Company News

Management tracks

...at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). Women's health and drug delivery company Juniper Pharmaceuticals Inc....
BioCentury | Aug 22, 2016
Clinical News

Lidocaine vaginal gel: Development discontinued

...missed the secondary endpoints of reducing post-procedural pain and cramping over 24 hours vs. placebo. Juniper Pharmaceuticals Inc....
BioCentury | Jul 20, 2016
Company News

Management tracks

...chairman, replacing Peter Corr. Franson will remain CMO of YourEncore (Indianapolis, Ind.). Women's health company Juniper Pharmaceuticals Inc....
BioCentury | Jul 18, 2016
Clinical News

Lidocaine vaginal gel: Phase I data

...a Phase IIb trial of COL-1077 to treat gynecological procedure-related pain are expected this quarter. Juniper Pharmaceuticals Inc....
BioCentury | Jul 18, 2016
Clinical News

Lidocaine vaginal gel: Completed Phase IIb enrollment

...a double-blind, placebo-controlled, U.S. Phase IIb trial evaluating a single dose of 150 mg COL-1077. Juniper Pharmaceuticals Inc....
BioCentury | Jul 18, 2016
Clinical News

OneCrinone regulatory update

...approved in 96 countries. Allergan has U.S. rights to Crinone. Allergan plc (NYSE:AGN), Dublin, Ireland Juniper Pharmaceuticals Inc....
BioCentury | Feb 15, 2016
Clinical News

Lidocaine vaginal gel: Phase IIb expanded

...enrolling women undergoing transvaginal pipelle-directed endometrial biopsy with tenaculum placement (see BioCentury, July 13, 2015). Juniper Pharmaceuticals Inc....
BioCentury | Jul 13, 2015
Clinical News

Lidocaine vaginal gel: Phase II started

...dose of 150 mg COL-1077 in 150 patients undergoing pipelle-directed endometrial biopsy with tenaculum placement. Juniper Pharmaceuticals Inc....
Items per page:
1 - 10 of 177
BioCentury | Oct 30, 2018
Company News

Management tracks: Blueprint, Clovis

...Mass.) hired Jeffrey Young as its first CFO. He was CFO, treasurer and secretary at Juniper Pharmaceuticals Inc....
BioCentury | Jun 9, 2017
Company News

Management tracks

...cancer company 2X Oncology Inc. (Cambridge, Mass.) named George Elston CEO. He was CFO at Juniper Pharmaceuticals Inc....
BioCentury | Jan 7, 2017
Company News

Management tracks

...at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). Women's health and drug delivery company Juniper Pharmaceuticals Inc....
BioCentury | Aug 22, 2016
Clinical News

Lidocaine vaginal gel: Development discontinued

...missed the secondary endpoints of reducing post-procedural pain and cramping over 24 hours vs. placebo. Juniper Pharmaceuticals Inc....
BioCentury | Jul 20, 2016
Company News

Management tracks

...chairman, replacing Peter Corr. Franson will remain CMO of YourEncore (Indianapolis, Ind.). Women's health company Juniper Pharmaceuticals Inc....
BioCentury | Jul 18, 2016
Clinical News

Lidocaine vaginal gel: Phase I data

...a Phase IIb trial of COL-1077 to treat gynecological procedure-related pain are expected this quarter. Juniper Pharmaceuticals Inc....
BioCentury | Jul 18, 2016
Clinical News

Lidocaine vaginal gel: Completed Phase IIb enrollment

...a double-blind, placebo-controlled, U.S. Phase IIb trial evaluating a single dose of 150 mg COL-1077. Juniper Pharmaceuticals Inc....
BioCentury | Jul 18, 2016
Clinical News

OneCrinone regulatory update

...approved in 96 countries. Allergan has U.S. rights to Crinone. Allergan plc (NYSE:AGN), Dublin, Ireland Juniper Pharmaceuticals Inc....
BioCentury | Feb 15, 2016
Clinical News

Lidocaine vaginal gel: Phase IIb expanded

...enrolling women undergoing transvaginal pipelle-directed endometrial biopsy with tenaculum placement (see BioCentury, July 13, 2015). Juniper Pharmaceuticals Inc....
BioCentury | Jul 13, 2015
Clinical News

Lidocaine vaginal gel: Phase II started

...dose of 150 mg COL-1077 in 150 patients undergoing pipelle-directed endometrial biopsy with tenaculum placement. Juniper Pharmaceuticals Inc....
Items per page:
1 - 10 of 177